Strategic joint ventures

Manufacturing of pharmaceutical products in Egypt across sterile and non-sterile streams, from essential medicines to specialised high-technology therapies.

A joint venture with Gypto Pharma, operator of a 180,000 m² pharmaceutical complex in Egypt with an annual capacity of 280 million units across four sterile and ten non-sterile production lines. The platform manufactures close to 75 commercialised products and is building capability in biosimilars, oncology and vaccines under cGMP standards — aligned with Egypt Vision 2030 and the group's mandate for national health security.

In partnership with Gypto Pharma — Egypt

Steel trading, project development and industrial services across the Middle East and North Africa.

A joint venture with the Swiss/Luxembourgish global steel trader Trasteel Holding S.A., extending the group's industrial reach across the MENA region.

In partnership with Trasteel Holding S.A. — Switzerland & Luxembourg

An end-to-end, investor-side governance and real estate development management platform for large-scale land banks across the UAE and GCC.

A partnership with Australia's PERIFA Developments introducing investor-side governance to large-scale land banks across the UAE and GCC markets.

In partnership with PERIFA Developments — Australia — development arm of Versatile Group

Specialized manufacturing in Egypt

In September 2019, Al Qalaa International Group signed a joint venture agreement for the manufacture of specialized products in Egypt. The venture brings together the group, its subsidiaries and partners from China and India. The agreement places production in Egypt, where the group maintains a regional office in Cairo. It is consistent with the group's industry and manufacturing sector and adds a further industrial undertaking to its operations in the country. The venture is structured as a partnership. Each party contributes to a single manufacturing operation, and the group participates directly and through its subsidiaries.

In partnership with Partners from China and India — China and India

Contract manufacturing and sales in Egypt and Africa

Al Qalaa International Group has signed a joint venture agreement with its partner for contract manufacturing and for the sale of the partner's manufactured products in Egypt and across Africa. The venture has two functions. It manufactures under contract, and it sells the resulting products in its target markets. Production and commercial distribution sit within a single structure. Al Qalaa contributes an established operating base in the United Arab Emirates and Egypt, with a regional office in Cairo. The partner supplies the products to be manufactured and sold. Further details on the partner, the product range and the start of operations will be published once confirmed.

In partnership with Healing Pharma Private Limited — India

Exclusive GCC partnership for manufactured steel products & Projects Execution

In 2019, Al Qalaa International Group signed a joint venture with Stancor Group. The agreement gives the venture an exclusive partnership in the GCC region for the steel products that Stancor Group manufactures. Exclusivity defines the scope of the venture: one partner, one product range and one region. It places the supply of these products under a single commercial relationship. Steel is an input to infrastructure, real estate and industrial work. Al Qalaa International Group is active in each of these sectors. The group is headquartered in Abu Dhabi and operates in the United Arab Emirates and Egypt. The venture belongs to the group's industry and manufacturing activity. It reflects the group's practice of building industrial partnerships with manufacturers.

In partnership with Stancor Group — India